Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma.
about
Xanthogranulomatous cholecystitis mimicking gallbladder carcinoma with a false-positive result on fluorodeoxyglucose PETCurrent diagnostic and management options in perihilar cholangiocarcinomaManagement of perihilar cholangiocarcinoma in the era of multimodal therapyClassification, diagnosis, and management of cholangiocarcinomaExpression of GLUT-1 and GLUT-3 in xanthogranulomatous cholecystitis induced a positive result on ¹⁸F-FDG PET: report of a caseDiagnosis of cholangiocarcinoma.Diagnostic performance of contrast enhanced CT and 18F-FDG PET/CT in suspicious recurrence of biliary tract cancer after curative resection.Nuclear imaging for functional evaluation and theragnosis in liver malignancy and transplantationMultimodality imaging of intrahepatic cholangiocarcinoma.Is there any role of positron emission tomography computed tomography for predicting resectability of gallbladder cancer?Prognostic Value of SUVmax Measured by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography in Patients with Gallbladder CancerClinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma.Expression of glucose transporters and hexokinase II in cholangiocellular carcinoma compared using [18F]-2-fluro-2-deoxy-D-glucose positron emission tomography.FDG-positron emission tomography/computed tomography and standardized uptake value in the primary diagnosis and staging of hilar cholangiocarcinoma.FDG-PET for hepatobiliary and pancreatic cancer: Advances and current limitations.Positron emission tomography/computer tomography: challenge to conventional imaging modalities in evaluating primary and metastatic liver malignanciesAppropriateness criteria of FDG PET/CT in oncology.NCCN clinical practice guidelines in oncology: hepatobiliary cancersImpact of pre-operative positron emission tomography in gallbladder cancer18F-FDG PET/CT Imaging of Gallbladder Adenocarcinoma - A Pictorial Review.Late Port Site Metastasis from Occult Gall Bladder Carcinoma After Laparoscopic Cholecystectomy for Cholelithiasis: The Role of (18)F-FDG PET/CTIs an aggressive surgical approach worthwhile in biliary cancer?Metabolic characteristics distinguishing intrahepatic cholangiocarcinoma: a negative pilot study of (18)F-fluorocholine PET/CT clarified by transcriptomic analysis.Gallbladder Carcinoma, the Difficulty of Early Detection: A Case Report.Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment.Does PET-CT scan have a role prior to radical re-resection for incidental gallbladder cancer?(11)C-Choline and FDG PET/CT Imaging of Primary Cholangiocarcinoma: A Comparative Analysis.Clinical impact of FDG PET-CT on management decisions for patients with primary biliary tumours.Therapeutical concepts and results for Klatskin tumorsAdvances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009Solitary rib recurrence of hilar cholangiocarcinoma 10 years after resection: report of a caseRisk factors of lymphatic metastasis complement poor radiological detection in gallbladder cancer.Diagnosis of biliary tract and ampullary carcinomas.The current role of PET-CT in the characterization of hepatobiliary malignancies.Intrahepatic cholangiocarcinoma: are we doing the right thing?Neoplasms of the hepatobiliary system: clinical presentation, molecular pathways and diagnostics.Cholangiocarcinoma: epidemiology, risk factors, pathogenesis, and diagnosis.Positron emission tomography in hepatobiliary and pancreatic malignancies: a review.Clinical applications of (18)F-FDG PET in the management of hepatobiliary and pancreatic tumors.Positron emission tomography in malignancies of the liver, pancreas and biliary tract - indications and potential pitfalls.
P2860
Q24656641-0C4AFE40-6D79-4A74-9B15-CE4432F38836Q26822808-EFACC470-66E8-4A0D-B981-CBB8523D0084Q28273788-76E853E0-3F2A-4E95-9369-D5FC53CEC21EQ28275153-CCD8FC02-C1DF-4233-A975-42C857FB0929Q30429669-81B1DA10-AA2E-4F1B-97F0-AA143C350D4DQ30493559-A38C9E1A-E213-4111-8CE9-BED8A99CB077Q31014798-8F9D1765-F768-49F8-AE76-784BF7CEB65AQ33594891-ACE0C4D7-D1EE-4301-B79B-0650602B5883Q33621543-7A8BF349-B025-4009-AEA6-55D27D462A6EQ33627586-486AC36F-11DC-42CC-9EB3-B3C069C0F9A8Q33639345-FD8142E2-0212-4C1C-9AF9-18057DBD16BBQ34614931-974251AA-8FD2-42C2-A34A-93DB33EAA16BQ34749773-154AD424-AB0E-4C8C-821F-666C6C22DD75Q34846267-50F12397-3502-4344-9E12-92C8020B1752Q35000851-1C93A035-73E6-41C4-AD1C-B16A4766B63BQ35397108-004CBDBE-7045-4815-AA48-4DE2F1CFD788Q35568776-49EB0B95-5BA3-4F9C-8D8B-61FD12A06BF8Q35703937-211CA5D5-9477-434B-BBF7-34B0EE8FACFDQ35805873-9163F3D9-9F7A-49C4-AA19-A76080A97C11Q36047838-3833789D-467E-47D4-8629-0006A602B028Q36064600-1CD2F8C4-604D-45D6-B18C-FFE2FD80B0A5Q36397621-DAE7DFB8-3769-4FDB-A74B-08614F840517Q36568339-BB11A5D3-B415-4E87-BFAC-66208B6934FEQ36689250-4BFA5535-1AAF-4B8F-A6B3-5151E467C79FQ36900063-1B0344E8-190F-4FD4-A487-7B0DF90B1409Q37002548-528FE70D-48D6-455E-802B-7198967F01ADQ37077299-E4FF8974-60C9-4B90-81AB-04C1E55F091CQ37192828-BE969D81-FC79-46B9-9F09-94F1EC3C3BEBQ37228433-B3CD3294-892F-4B3F-9834-383F79A1CD1BQ37347327-7DB1B231-7F06-4105-BE30-9E19CB4E41F1Q37365713-86C73EFE-81C0-4E3F-BC7D-240EA56C7A82Q37454519-E900FAEA-BF22-4466-9E33-EE126C4344F7Q37478201-6CA8BCEB-689B-40E1-941A-8E237EE7DBDFQ37546832-C0131417-B9A6-47D2-8953-EA16E75833BAQ37584854-C437A60A-A73B-4A0F-A3CC-9CD009F3D3ADQ37801938-68B8A358-7389-42B9-BDB8-E56E48B2D0B1Q37832697-E849BDB6-980B-4C18-86BD-413B5E4A0C7DQ37998654-1B0351E4-DC08-4392-B544-E544C76BF623Q38004855-BCE2B69C-CE87-4A7A-9D95-08F87871CC36Q38059510-AA3A612D-EC40-434F-A2BE-0369B7521651
P2860
Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Impact of integrated positron ...... cancer and cholangiocarcinoma.
@en
Impact of integrated positron ...... cancer and cholangiocarcinoma.
@nl
type
label
Impact of integrated positron ...... cancer and cholangiocarcinoma.
@en
Impact of integrated positron ...... cancer and cholangiocarcinoma.
@nl
prefLabel
Impact of integrated positron ...... cancer and cholangiocarcinoma.
@en
Impact of integrated positron ...... cancer and cholangiocarcinoma.
@nl
P2093
P1476
Impact of integrated positron ...... cancer and cholangiocarcinoma.
@en
P2093
Daniela B Husarik
Henrik Petrowsky
Peer Wildbrett
Simona Tam
Thomas F Hany
Wolfram Jochum
P356
10.1016/J.JHEP.2006.03.009
P577
2006-04-19T00:00:00Z